Association of collagen deep learning classifier with prognosis and chemotherapy benefits in stage II-III colon cancer.
Ontology highlight
ABSTRACT: The current tumor-node-metastasis staging system does not provide sufficient prognostic prediction or adjuvant chemotherapy benefit information for stage II-III colon cancer (CC) patients. Collagen in the tumor microenvironment affects the biological behaviors and chemotherapy response of cancer cells. Hence, in this study, we proposed a collagen deep learning (collagenDL) classifier based on the 50-layer residual network model for predicting disease-free survival (DFS) and overall survival (OS). The collagenDL classifier was significantly associated with DFS and OS (P < 0.001). The collagenDL nomogram, integrating the collagenDL classifier and three clinicopathologic predictors, improved the prediction performance, which showed satisfacto
SUBMITTER: Jiang W
PROVIDER: S-EPMC10189440 | biostudies-literature | 2023 May
REPOSITORIES: biostudies-literature
ACCESS DATA